REVOSHIELD+
Commercial- Indications
- Wound healing
Company intelligence / Profile preview
Total Ancillary provides a comprehensive suite of advanced wound care products—including biologic skin substitutes—and a proprietary SaaS platform, Healthview 360™, to streamline clinical operations. The company focuses on improving patient outcomes through innovative regenerative therapies and efficient practice management. No specific clinical trial results are disclosed; the business is positioned as a commercial-stage provider supporting healthcare practices with both products and administrative tools.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Total Ancillary.